Objective To compare GH responses to an oral GH secretagogue, LUM-201 (ibutamoren, formerly MK-0677) and standard GH stimulation tests used for diagnosis of pediatric growth hormone deficiency (PGHD) Introduction LUM-201 is an orally administered agonist of the growth hormone secretagogue...
https://lifescievents.com/event/lumos-pharma-kol-webinar-discussing-interim-results-from-two-phase-2-lum-201-trials-for-pediatric-growth-hormone-deficiency/ Lumos Pharma KOL Webinar Discussing Interim Results from Two Phase 2 LUM-201 Trials for Pediatric Growth Hormone Deficiency
https://empoweredpatientradio.com/oral-treatment-for-rare-disease-pediatric-growth-hormone-deficiency-with-rick-hawkins-lumos-pharma Rick Hawkins, CEO, and Chairman of Lumos Pharma is developing an oral compound to treat idiopathic pediatric growth hormone deficiency. Currently, the only...
https://endocrinenews.endocrine.org/such-great-heights/ Fernando Cassorla, MD, is traveling from Chile to Chicago to present research at ENDO 2023 that could potentially change the way pediatric hormone treatments are administered. If a pill could replace painful injections, patients and...
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.